Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Both treatments for pemphigus foliaceus in dogs are effective, but combination therapy has more side effects.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

More research is needed to understand hair and scalp disorders in people with skin of color.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.